[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369078-105":59,"doc-detail-369078-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predisposition-footprints-in-the-somatic-genome-of-wilms-tumours","Predisposition footprints in the somatic genome of Wilms tumours","","Ten percent of children with cancer carry mutations in a predisposition gene, and in Wilms tumour the prevalence can reach 30%. Predisposition states often correlate with distinct histological and clinical features, implying differences in tumourigenesis. A cohort of 137 Wilms tumour patients was assembled, with 71 carrying pathogenic germline or mosaic variants. Across 237 neoplasms, including two secondary leukaemias, the study used WGS, RNA sequencing, and genome-wide methylation, and validated results in an independent cohort. Tumour development varied by variant gene and developmental timing, affecting driver event repertoires, clonal architecture of normal kidneys, and relationships among neoplasms from the same individual, supporting variant-specific management considerations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predisposition-footprints-in-the-somatic-genome-of-wilms-tumours/369078/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predisposition-footprints-in-the-somatic-genome-of-wilms-tumours/369078.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How common are predisposition gene mutations in children with cancer and in Wilms tumour?","Question",{"text":112,"@type":113},"About 10% of children with cancer have mutations in a predisposition gene, and in Wilms tumour the prevalence can be as high as 30%. These values are reported in the document’s abstract and introduction.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cohort and study methods were used to investigate Wilms tumour predisposition?",{"text":117,"@type":113},"The study assembled 137 children with Wilms tumour, including 71 with pathogenic germline or mosaic variants. It analyzed 237 neoplasms using WGS, RNA sequencing, and genome-wide methylation, with validation in an independent cohort.",{"name":119,"@type":110,"acceptedAnswer":120},"How did tumour development differ among children with different predisposition variants?",{"text":121,"@type":113},"Tumour development differed depending on the variant gene and its developmental timing. Differences were observed across driver event repertoires, the clonal architecture of normal kidneys, and the relatedness of neoplasms within the same individual.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369078,1790216740,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Europe PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nEurope PMC Funders Group  \nAuthor Manuscript  \nCancer Discov. Author manuscript; available in PMC 2025 January 09.  \nPublished in final edited form as:  \nCancer Discov. 2025 February 07; 15(2): 286–298. doi:10.1158/2159-8290.CD-24-0878 .  \nPredisposition footprints in the somatic genome of Wilms tumours  \nTaryn D. Treger\\#1,2,3 , Jenny Wegert \\#4 , Anna Wenger\\#1 , Tim H. H. Coorens\\#5 , Reem AlSaadi7,8 , Paul G. Kemps 1,6 , Jonathan Kennedy 1,7 , Conor Parks 1 , Nathaniel D. Anderson 1 , Angus Hodder1,7 , Aleksandra Letunovska6 , Hyunchul Jung 1 , Toochi Ogbonnah 1 , Mi  \nK. Trinh 1 , Henry Lee-Six 1,3 , Guillaume Morcrette9 , Marry M van den Heuvel-Eibrink6 , Jarno Drost6,11 , Ruben van Boxtel6,11 , Eline J. M. Bertrums6 , Bianca F. Goemans6 , Evangelia Antoniou 12,13 , Dirk Reinhardt 12,13 , Heike Streitenberger4 , Barbara Ziegler4 , Jack Bartram7,8 , J. Ciaran Hutchinson7 , Gordan M. Vujanic 10 , Christian Vokuhl 14 , Tanzina Chowdhury7,8 , Rhoikos Furtwängler15,16 , Norbert Graf15 , Kathy Pritchard-Jones8,* , Manfred Gessler4,17,* , Sam Behjati 1,2,3,7,*  \n1Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.  \n2 Department of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK.  \n3Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.  \n4Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, University of Wuerzburg, Wuerzburg, Germany.  \n5Broad Institute of MIT and Harvard, Cambridge, 02142 MA, USA.  \n6 Princess Máxima Center for pediatric oncology, Heidelberglaan 25, 3584CS, Utrecht, The Netherlands  \n7Great Ormond Street Hospital for Children, London, WC1N 3JH, UK.  \n8 UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK  \n9 Department of fetopathology, Robert Debré University Hospital, Assistance publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.  \n10 Department of Pathology, Sidra Medicine, Doha, Qatar  \nThis work is licensed under a BY 4.0 International license.  \nCorrespondence to: Kathy Pritchard-Jones; Manfred Gessler.  \nContact addresses: k.pritchard-jones@ucl.ac.uk UCL Great Ormond Street Institute of Child Health, Guilford Street, London, WC1N 1EH, United Kingdom; +442079052774, manfred.gessler@uni-wuerzburg.de University ofWuerzburg, Am Hubland, 97074, Würzburg; +499313184160 [sb31@sanger.ac.uk Wellcome Trust Genome Campus](sb31@sanger.ac.uk Wellcome Trust Genome Campus), Hinxton, Saffron Walden CB10 1RQ; 00441223 8*342Co-r.responding and co-directing authors  \nAuthor Contributions: S.B., T.D.T. and T.H.H.C. designed the experiment. T.D.T. performed overall data analysis aided by J.W.(extension cohort), A.W. (phylogenetic analyses, methylation clustering), and T.H.H.C. (signature analyses; analysis of normal tissue clones) . P.K., N.D.A., A.H., H.J. M.T. further contributed to data analysis. The following authors prepared samples and / or provided clinical data and expertise and / or prepared experiments: J.W., R.A.S., J.K., C.P., T.O., A.L., J.D., R.v.B., E.B., B.G., M.v.d.H.E., E.A., D.R., B.Z., H.S., J.B., R.F., N.G., T.C. Pathology expertise was provided by H.L.S., G.M., C.H., G.V., and C.V. K.P.J., M.G., and [S.B. co-directed the](S.B. co-directed the) study. S.B. and T.D.T. wrote the manuscript.  \nThe authors declare no potential conflicts of interest.  \nEurope PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nTreger et al. Page 2  \n11Oncode Institute, Utrecht, The Netherlands.  \n12Clinic of Pediatrics III, University Hospital of Essen, Essen, Germany.  \n13AML-BFM Study Group, Germany  \n14 Department of Pathology, Section of Pediatric Pathology, University of Bonn, Bonn, Germany.  \n15 Department of Paediatric Haematology and Oncology, Saarland University, Homburg, Germany.  \n16 Pediatric Hematology and Oncology, Inselspital Children’s Hospital, University Bern, Bern, Switzerland.  \n17Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Wue","cbCaimpiY6TKc9kh","https://ap.wps.com/l/cbCaimpiY6TKc9kh","pdf",1966104,26,"English","# Abstract\n# Introduction","[{\"question\":\"How common are predisposition gene mutations in children with cancer and in Wilms tumour?\",\"answer\":\"About 10% of children with cancer have mutations in a predisposition gene, and in Wilms tumour the prevalence can be as high as 30%. These values are reported in the document’s abstract and introduction.\"},{\"question\":\"What cohort and study methods were used to investigate Wilms tumour predisposition?\",\"answer\":\"The study assembled 137 children with Wilms tumour, including 71 with pathogenic germline or mosaic variants. It analyzed 237 neoplasms using WGS, RNA sequencing, and genome-wide methylation, with validation in an independent cohort.\"},{\"question\":\"How did tumour development differ among children with different predisposition variants?\",\"answer\":\"Tumour development differed depending on the variant gene and its developmental timing. Differences were observed across driver event repertoires, the clonal architecture of normal kidneys, and the relatedness of neoplasms within the same individual.\"}]","Predisposition footprints in the somatic genome of Wilms tumours | PDF",1790180541,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d36e3bc035995d2aeb4ec3f357ee379.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffd0d93843c503d6fbbdf0eca1eddb79.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17bff1c059aaa87c95e30c5a2b95bb50.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02d8b9084697766f49db2cf2215efb1a.webp",980,1268]